Review Medical sciences · 2026 Treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal, Hepatic, Endocrine, Neurological, and Postoperative Diseases: A Comprehensive Narrative Review. Maslennikov R, Agarkova V, Poluektova E, et al. Saccharomyces cerevisiae PubMed ↗
Observational The Journal of clinical endocrinology and metabolism · 2026 Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations. Wei M, Mehravar S, Leite G, et al. Klebsiella PubMed ↗
Review Current opinion in gastroenterology · 2025 Modern concepts of small intestinal bacterial overgrowth. Barlow GM, Pimentel M Klebsiella PubMed ↗
Randomized trial Terapevticheskii arkhiv · 2025 [Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors]. Maev IV, Andreev DN, Shaburov RI, et al. Saccharomyces cerevisiae PubMed ↗
Observational Digestive and liver disease · 2024 Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth. Lu S, Chen Y, Guo H, et al. EscherichiaLachnoclostridium PubMed ↗
Clinical and translational gastroenterology · 2026 Alterations in Oral Cecal Transit Time and Small Intestinal Microbiota in Minimal Hepatic Encephalopathy With Small Intestinal Bacterial Overgrowth. Cao L, Meng Y, Huang Y, et al. ActinomycesBacillusRothia PubMed ↗
Digestive diseases and sciences · 2021 Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes. Weitsman S, Celly S, Leite G, et al. Clostridium PubMed ↗